Introduction: Malaria continues to pose a public health challenge in Ghana particularly in pregnant women. Ghana adopted intermittent
Introduction
Malaria is an enormous international health problem affecting mainly young children, pregnant women and adults with little or no immunity. Over 25 million pregnant women are at risk of the infection each year worldwide. Malaria in pregnancy may result in maternal and foetal anaemia, prematurity, stillbirths, rarely congenital malaria as well low birth weight which is the single greatest risk factor for neonatal deaths [1, 2] . More than 30 million women in Africa become pregnant in malaria endemic areas and are at risk of Plasmodium falciparum malaria infection compared to nonpregnant women. Yet only a fraction of these women have access to effective anti-malaria interventions [3] . The susceptibility of pregnant women to Plasmodium Falciparum malaria increases the risk of disease and a high incidence of death for both the mother and her foetus [4] . In Ghana, malaria among pregnant women accounts for about 14% of Out Patient Department (OPD) attendance, 11% of admissions and 9% of deaths [5] . Malaria in pregnancy may occur depending on a woman's exposure to mosquitoes, her level of immunity and possible co-infections such as other malaria species, HIV or helminths as well as the efficacy of treatment and preventive interventions available to her [6] . Even though adult women in malaria endemic areas have a high level of immunity, this generally is impaired during pregnancy particularly in the first pregnancy, thereby increasing their risk of infection [7] .
This increased risk has been attributed to the immunological, hormonal and physiological changes in pregnancy [8] . The reduced immunity may result in the risk of acute and severe clinical disease as well as more frequent episodes [2] . Although malaria in pregnancy may sometimes be asymptomatic, it can still affect the health of a woman and that of her unborn child. This was based on growing concerns of resistance to Chloroquine and the fact that only 11.6% were adhering to the policy of using Chloroquine as IPT [1] . The new policy of Intermittent Preventive Treatment in pregnancy (IPTp) using SP was piloted in 20 selected districts of Ghana and by 2005 scaled up to a nationwide coverage.
A revision of the policy was done in 2007 and the revised current policy was formulated in 2012 [9] . According to the policy, IPT was to be implemented as part of a multipronged approach as recommended by WHO to reduce the burden of malaria in pregnancy. These approaches consist of three tenets; which include the use of SP as IPTp, Insecticide Treated Nets (ITN) and case management of malaria illness. A clinic-based prevention approach was adopted as over 90% of the target (pregnant women) attend antenatal clinic at least once during pregnancy [1, 10] . Intermittent preventive treatment of malaria in pregnancy is based on the assumption that every pregnant woman living in areas of high malaria transmission has malaria parasites in her blood or placenta, whether or not she has symptoms of malaria. It involves the administration of treatment doses of SP in at least monthly intervals during pregnancy with the first dose administered as early as possible in the second trimester and the last dose administered up to the time of delivery [11] . The potential of IPT to achieve great levels of programme coverage due to high level of acceptability by women and its benefits in reducing malaria in pregnancy which causes maternal anaemia and Low Birth Weight (LBW) makes it a preferred strategy [5] . According to the Ministry of Health, every pregnant woman is expected to receive at least two doses of SP under Directly Observed Therapy (DOT) [1] . Although Ghana has adopted WHO recommendations on the use of SP for IPTp, IPT2 coverage remains generally low [12] . Like many other endemic countries, Ghana's ability to achieve the global target of 80% IPT2 coverage still poses a great challenge [13] [14] [15] . However, not much has been documented about the knowledge of pregnant women on IPT and malaria in pregnancy as well as factors that influence the uptake of IPT of Malaria in Pregnancy using SP among pregnant women. This study therefore will determine the factors that influence the uptake of IPT of Malaria in Pregnancy using SP among pregnant women.
Methods
Settings, population and study design: this was a cross-sectional Sample size: a sample size of 384 was calculated based on the sample size formula for a single population. This was estimated using an expected IPT3 prevalence of 50% in the Sunyani Municipality [17] . This sample had a margin of error of 5% and confidence interval of 95%. This was calculated using the formula:
Where: n = the minimum required sample size. z = standard normal deviation corresponding to 95% confidence interval, which equals to 1.96. P= proportion of pregnant women who received IPT3 taken to be 50% E = the margin of error on P estimated to be at 5%. Therefore: n = 384. Adjusting for 10% of non-response rate, a total 422 participants were required for the study. Permission was also sought from health facility managers where the study was conducted. Written informed consent was obtained from study participants after they were well informed about the study.
Participants were not pressured to take part in the study and were informed about the purpose of the study. They were also assured of full confidentiality of information they provided and their right to withdraw from the study even after they have participated.
Limitations of the study: some of the pregnant women might not have given accurate responses because they might be aware of the national policy on SP in pregnancy or they might be afraid that their responses might incriminate their healthcare providers. However, we assured them of privacy and confidentiality of the information they provided. Some of the study participants did not understand the English language so we had to make use of the local language to interview them.
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Results Table 1 shows socio-demographic characteristics of 400 participants who took part in the study. Most of the respondents were within the age group of 25-29years, 37.8% (151/400). Of the 400 participants who took part in the study, 86.5% (346/400) of them were married whilst 9% (36/400) were single. Most of the participants were multiparous, 45.2% (181/400). Most of the participants involved in the study were educated at postbasic level, 56.5% (226/400).
Majority of the participants were employed, 90.3% (361/400).
Majority of the respondents were within the age groups of 37.8%
(151/400) and 30.3% (121/400). The mean age of respondents in the study was 29.1 ± 4.9 with a range of 16-44 years. Table   2 (142/400) in Ghana. Coverage of SP is summarized in Figure 1 below. The uptake of SP by the pregnant women ranged between 0 and 5 doses. An average of 3 doses received is considered optimal IPT uptake. Majority of the women, 44% (176/400) had received 3 doses while only 1.5% (6/400) received no dose of SP at 36 weeks gestation or above.
Discussion
Findings from this study suggest that 98.5% of pregnant women received at least one dose of SP in the Sunyani Municipality.
Approximately 91% of pregnant women received at least 2 doses of SP and 71% received 3 or more doses of SP. The national target of IPTp is 100% of at least two dose of SP. The coverage of 91% of at least IPT2 suggests that although IPTp-SP usage is high, it is still below the national target [17] . Also, the coverage of 71% receiving at least 3 doses of SP in this study is higher than the national figure (39%) reported for IPTp 3 coverage in the 2014 Ghana
Demographic and Health Survey and also higher than 23% of IPTp 3 reported by WHO [11, 18] . The difference in the proportions of IPT3 uptake reported in this study (71%) and the national figure (39%), only underscore the different variations of IPTp uptake in Ghana. For instance, a similar study by Antwi in Bosomtwi district found that over 95% of received at least one dose of SP, which is consistent with the findings of this study [19] . The educational level of the study participants was significantly associated with the optimal (≥3 doses of SP) uptake of IPTp-SP. This might be due to the fact that education enables people to be well informed and make informed decisions and choices especially on maternal health issues. Women who are educated better appreciate the complications associated with pregnancy and childbirth and are more likely to receive optimal doses of SP [20] . Also, Sunyani
Township is both a municipality and a regional capital, thus majority of the pregnant women were probably in the working group, found that parity had no significant effect on receiving optimal doses of SP [21, 22] . This could possibly be because women are
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More than 70% of respondents in this study had good knowledge of facility. This study found that majority of the women made their first ANC visit at a median gestational age of 15 weeks which is comparable to findings in Bosomtwe district where the median gestational age at first ANC was 16 weeks [19] . This implies that women in the Sunyani Municipality attend antenatal clinics at an early gestational age but this did not make a significant difference on SP uptake. This is similar to findings by a study in Northern
Nigeria that found that early gestation at booking was not associated with IPTp uptake among pregnant women [21] . Over 90% of the respondents in this study made four or more ANC visits.
The number of recommended visits by WHO is at least four visits for no risk pregnancy. This study observed that attending antenatal care for four or more times was significantly associated with receiving optimal doses of SP. This finding is in consonance with many other studies that demonstrated that making four or more ANC visits is significantly related to receiving more doses of SP [19, 28, 29] . The age group and marital status of respondents was not significantly associated with the uptake of optimal doses of SP among pregnant women. This finding was inconsistent with studies conducted in Tanzania that observed that age group and marital status of pregnant women influenced the uptake of optimal doses of SP [30] .
Conclusion
This study has demonstrated that education, having a good knowledge of IPTp and malaria in pregnancy as well as four or more ANC visits significantly influenced the uptake of optimal IPTp doses.
Education of women on IPTp and malaria in pregnancy should be intensified. Follow up visits or contacts should also be made on pregnant women who initiate ANC to encourage them to return for SP. 
What is known about this topic
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